Independent minds. Global perspective. A publication for the builders
Biotechnology / London, United Kingdom

Shanil Panara.

Co-founder
Nanograb

Shanil Panara co-founded Nanograb and leads its computational work after leaving doctoral study at Imperial College London. His interests center on computing and physics. Nanograb researches AI-designed combinations of molecular binders and nanoparticles for targeted delivery of genetic medicines.

Public-source researchLast checked 1 source ↘
THE STORY, IN CONTEXT

Shanil Panara and the story of Nanograb.

Nanograb's launch describes a research approach combining computational design with multivalent biophysics. Panara's role concerns building and deploying the computational pipeline alongside scientific colleagues with related theoretical and experimental expertise. Earlier materials discuss proof-of-concept research; later ones introduce a named platform for delivery applications. This is a company account of biotechnology development, and its broad therapeutic promises are not presented as proven clinical outcomes or advice about treatment.

FROM THE PUBLIC RECORD

Public advice & further reading.

No personal advice is attributed in this profile: a verifiable public advice source has not yet been established. The company and activity facts above remain separately sourced.

Suggest a first-person interview or essay ↗
EVIDENCE IN PLAIN SIGHT

Sources & attribution.

  1. 01
    Nanograb — Y Combinator company and active founder profile

    Public active-founder biography, current company status and description, and founding-team launch accounts. Company or team statements are attributed accounts, not independently audited performance results.

    www.ycombinator.com
About this profile

Independently researched from the public sources above. Featured people and companies are not affiliated with BusinessBlogz. Source dates and attribution provide context for the information shown; business claims remain attributed to their original source. Role and company details can change after review. The initials graphic is editorial artwork, not a photograph.

Request a correction or update ↗
KEEP EXPLORING

More builders in Biotechnology.

Explore the sector ↗